Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia
Condition(s):Fanconi AnemiaLast Updated:October 12, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Fanconi AnemiaLast Updated:October 12, 2021Completed
Condition(s):Fanconi AnemiaLast Updated:August 10, 2016Completed
Condition(s):Fanconi Anemia; Severe Aplastic AnemiaLast Updated:May 24, 2018Terminated
Condition(s):FANCONI ANEMIALast Updated:March 4, 2014Terminated
Condition(s):Fanconi AnemiaLast Updated:October 30, 2020Completed
Condition(s):Acute Myeloid Leukemia in Remission; de Novo Myelodysplastic Syndrome; Fanconi Anemia; Previously Treated Myelodysplastic SyndromeLast Updated:January 29, 2020Completed
Condition(s):Cystic Fibrosis; Pseudohypoaldosteronism; Nontuberculous Mycobacterial Infection; Chronic Granulomatous Disease; Primary Ciliary DyskinesiaLast Updated:March 13, 2024Completed
Condition(s):Fanconi AnemiaLast Updated:June 23, 2017Completed
Condition(s):Fanconi AnemiaLast Updated:November 24, 2021Completed
Condition(s):Kartagener Syndrome; Cystic Fibrosis; Pseudohypoaldosteronism; Primary Ciliary DyskinesiaLast Updated:August 10, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.